Loading...
Loading...
Given Imaging
GIVN, a world leader in specialty GI products and pioneer of capsule
endoscopy, today announced new data on recommendations for early use
of PillCam SB, as well as new technological advances. Given Imaging
also announced new studies confirming PillCam(R) SB's benefits in
several specialized patient populations, including octogenarians and
those with neutropenic cancer, for whom the minimally-invasive
procedure might be a safer alternative to other diagnostic methods.
The studies are being presented at the American Society for
Gastrointestinal Endoscopy (ASGE) Research Forum at Digestive Disease
Week(R) (DDW), taking place May 19 - 22 in San Diego.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in